timothy sykes logo
HTFL Surges As Heartflow Lifts 2026 Revenue Outlook Thumbnail
G Google News

HTFL Surges As Heartflow Lifts 2026 Revenue Outlook

TIM SYKES•UPDATED AUG. 16, 2026, 11:06 AM ET
Reviewed by Jack Kelloggand Fact-checked by Ellis Hobbs

Heartflow, Inc. stocks have been trading up by 35.83 percent after strong clinical adoption headlines boosted investor optimism.

What Traders Need To Know

  • Shares spiked as much as 33% after a Q2 print showing a narrower non-GAAP loss, higher revenue, and a raised 2026 revenue outlook.
  • Strong single-day momentum followed multiple reports of 24%+ price jumps tied to the same Q2 catalyst and improved guidance.
  • Earnings showed a narrower-than-expected Q2 loss with revenue growth, signaling better execution than feared.
  • The sharp move pushes HTFL into a new price zone, where prior resistance levels offer reference points for short-term traders.

Candlestick Chart

Weekly Update Aug 10 – Aug 14, 2026: On Sunday, August 16, 2026 Heartflow, Inc. stock [NASDAQ: HTFL] is trending up by 35.83%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Healthcare industry expert:

Analyst sentiment – positive

Heartflow (HTFL) is an emerging cardiac diagnostics platform with strong gross margins (78.1%) but deeply negative operating profitability (EBIT margin -53.2%, EBITDA margin -46.2%) and ROE of -87%. Q2 revenue of ~$64.1M (LTM ~$176M) supports a modest enterprise value/revenue multiple (~20x) given EV of $3.5B, implying high embedded growth expectations. Liquidity is robust (current ratio 5.6, quick 5.1, net cash position, low leverage at 0.09x D/E), but free cash flow remains negative (-$10.5M), dependent on capital markets until scale is achieved.

The stock’s weekly tape shows a violent upside repricing from ~29.9 to 42.1 in four sessions, with a clear gap and acceleration day at 38.5, confirming a sharp trend shift to bullish momentum. The 38–39 zone now represents critical breakout support; any pullback holding that level offers a defined-risk entry. Intraday 5‑minute action likely featured heavy volume on the gap and consolidation near the highs, suggesting strong institutional demand. Actionable level: buy near 38–39 with a stop below 36 and near-term upside toward the mid‑40s.

Recent news of a narrower Q2 loss, higher revenue, and raised 2026 outlook triggered a 24–33% spike, materially re-rating expectations versus Healthcare and Providers & Services peers, where growth is slower and profitability stronger but upside more limited. Heartflow now screens as a high-growth, loss-making outlier with superior balance sheet strength. Near term, expect consolidation between $38 support and $45 resistance; base case 6–12 month upside target is $50 as execution de-risks the path to breakeven.

More Breaking News

Quick Financial Overview

Heartflow, Inc. (HTFL) just delivered the kind of catalyst short-term traders look for: a clean earnings beat on losses, revenue growth, and a higher 2026 outlook, all triggering a 30%+ surge. Q2 revenue of about $64.1M sits on a base of roughly $176.0M over the last twelve months, confirming a growing top line. At the same time, Q2 net loss of about $15.7M and EBITDA of around -$13.5M highlight that HTFL is still firmly in “growth-mode burn,” not yet a profit story.

Margins frame that tension clearly. A gross margin of 78.1% is strong, showing the core product economics are attractive once scale is there. But the EBIT margin of -53.2% and profit margin near -58% reflect heavy operating spend, mainly in research and selling costs, that is still outpacing revenue. Negative free cash flow of roughly -$10.5M in the quarter confirms the cash burn, though a current ratio of 5.6 and long-term debt to capital near 0.07 suggest Heartflow, Inc. has room to fund growth.

On the chart, that bullish Q2 headline fuelled a clear repricing. Weekly data show HTFL grinding around the high-$20s for several days, then gapping straight to $38.5 and pushing above $42. That is a textbook earnings gap-and-go, backed by an intraday range from roughly $36.0 to $43.0 before closing near $42.1. For traders, the prior high-$20s area now acts as the old base, while the $38–$43 band is the new battleground where momentum, profit taking, and any follow-through buying will sort out the next leg.

Conclusion

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

How much has this post helped you?

(0 votes, average: 0 out of 5)
Leave a reply

* Results are not typical and will vary from person to person. Making money trading stocks takes time, dedication, and hard work. There are inherent risks involved with investing in the stock market, including the loss of your investment. Past performance in the market is not indicative of future results. Any investment is at your own risk. See Terms of Service here

The available research on day trading suggests that most active traders lose money. Fees and overtrading are major contributors to these losses.

A 2000 study called “Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors” evaluated 66,465 U.S. households that held stocks from 1991 to 1996. The households that traded most averaged an 11.4% annual return during a period where the overall market gained 17.9%. These lower returns were attributed to overconfidence.

A 2014 paper (revised 2019) titled “Learning Fast or Slow?” analyzed the complete transaction history of the Taiwan Stock Exchange between 1992 and 2006. It looked at the ongoing performance of day traders in this sample, and found that 97% of day traders can expect to lose money from trading, and more than 90% of all day trading volume can be traced to investors who predictably lose money. Additionally, it tied the behavior of gamblers and drivers who get more speeding tickets to overtrading, and cited studies showing that legalized gambling has an inverse effect on trading volume.

A 2019 research study (revised 2020) called “Day Trading for a Living?” observed 19,646 Brazilian futures contract traders who started day trading from 2013 to 2015, and recorded two years of their trading activity. The study authors found that 97% of traders with more than 300 days actively trading lost money, and only 1.1% earned more than the Brazilian minimum wage ($16 USD per day). They hypothesized that the greater returns shown in previous studies did not differentiate between frequent day traders and those who traded rarely, and that more frequent trading activity decreases the chance of profitability.

These studies show the wide variance of the available data on day trading profitability. One thing that seems clear from the research is that most day traders lose money .

Millionaire Media 66 W Flagler St. Ste. 900 Miami, FL 33130 United States (888) 878-3621 This is for information purposes only as Millionaire Media LLC nor Timothy Sykes is registered as a securities broker-dealer or an investment adviser. No information herein is intended as securities brokerage, investment, tax, accounting or legal advice, as an offer or solicitation of an offer to sell or buy, or as an endorsement, recommendation or sponsorship of any company, security or fund. Millionaire Media LLC and Timothy Sykes cannot and does not assess, verify or guarantee the adequacy, accuracy or completeness of any information, the suitability or profitability of any particular investment, or the potential value of any investment or informational source. The reader bears responsibility for his/her own investment research and decisions, should seek the advice of a qualified securities professional before making any investment, and investigate and fully understand any and all risks before investing. Millionaire Media LLC and Timothy Sykes in no way warrants the solvency, financial condition, or investment advisability of any of the securities mentioned in communications or websites. In addition, Millionaire Media LLC and Timothy Sykes accepts no liability whatsoever for any direct or consequential loss arising from any use of this information. This information is not intended to be used as the sole basis of any investment decision, nor should it be construed as advice designed to meet the investment needs of any particular investor. Past performance is not necessarily indicative of future returns.

Citations for Disclaimer

Barber, Brad M. and Odean, Terrance, Trading is Hazardous to Your Wealth: The Common Stock Investment Performance of Individual Investors. Available at SSRN: “Day Trading for a Living?”

Barber, Brad M. and Lee, Yi-Tsung and Liu, Yu-Jane and Odean, Terrance and Zhang, Ke, Learning Fast or Slow? (May 28, 2019). Forthcoming: Review of Asset Pricing Studies, Available at SSRN: “https://ssrn.com/abstract=2535636”

Chague, Fernando and De-Losso, Rodrigo and Giovannetti, Bruno, Day Trading for a Living? (June 11, 2020). Available at SSRN: “https://ssrn.com/abstract=3423101”